Study Finds Remdesivir Benefits Patients with COVID-19, Results in Greater Clinical Improvement
June 2nd 2020The FDA granted an Emergency Use Authorization for the drug in hospitalized patients with severe COVID-19, but the authorization does not take the place of a formal new drug approval process.
Read More
FDA Approves Flortaucipir F18 For Patients Being Evaluated for Alzheimer Disease
May 29th 2020Officials from the FDA have approved flortaucipir F18 (Tauvid, Eli Lilly) for intravenous injection as the first drug used to help image a distinctive characteristic of Alzheimer disease in the brain called tau pathology.
Read More